- Home
- TGNA vs RXRX Comparison
TGNA vs RXRX Comparison
Compare TGNA & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGNA
- RXRX
- Stock Information
- Founded
- TGNA 1906
- RXRX 2013
- Country
- TGNA United States
- RXRX United States
- Employees
- TGNA N/A
- RXRX N/A
- Industry
- TGNA Broadcasting
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- TGNA Industrials
- RXRX Health Care
- Exchange
- TGNA Nasdaq
- RXRX Nasdaq
- Market Cap
- TGNA 2.9B
- RXRX 2.6B
- IPO Year
- TGNA N/A
- RXRX 2021
- Fundamental
- Price
- TGNA $17.80
- RXRX $6.59
- Analyst Decision
- TGNA Strong Buy
- RXRX Buy
- Analyst Count
- TGNA 4
- RXRX 4
- Target Price
- TGNA $21.75
- RXRX $8.25
- AVG Volume (30 Days)
- TGNA 1.7M
- RXRX 34.0M
- Earning Date
- TGNA 02-27-2025
- RXRX 02-28-2025
- Dividend Yield
- TGNA 2.81%
- RXRX N/A
- EPS Growth
- TGNA 54.82
- RXRX N/A
- EPS
- TGNA 3.53
- RXRX N/A
- Revenue
- TGNA $3,101,971,000.00
- RXRX $58,839,000.00
- Revenue This Year
- TGNA N/A
- RXRX $60.46
- Revenue Next Year
- TGNA $10.64
- RXRX $33.76
- P/E Ratio
- TGNA $5.04
- RXRX N/A
- Revenue Growth
- TGNA 6.56
- RXRX 32.00
- 52 Week Low
- TGNA $12.35
- RXRX $5.60
- 52 Week High
- TGNA $19.62
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- TGNA 49.59
- RXRX 39.75
- Support Level
- TGNA $16.99
- RXRX $6.15
- Resistance Level
- TGNA $18.85
- RXRX $6.77
- Average True Range (ATR)
- TGNA 0.63
- RXRX 1.01
- MACD
- TGNA 0.00
- RXRX -0.35
- Stochastic Oscillator
- TGNA 55.88
- RXRX 7.09
About TGNA TEGNA Inc
Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.